Skip to main content
  • Outcomes of Cardiogenic Shock With Autoimmune Rheumatological Disorders

    Abstract

    Aims

    Data on cardiogenic shock (CS) in autoimmune diseases (AID) is limited. Our study aims to evaluate in-hospital outcomes of CS in hospitalized patients with underlying AID compared with patients without AID.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details